Booster vaccination at 6-8 years of age with a reduced antigen content dTpa- IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine: Human Vaccines: Vol 4, No 1
Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV): Human Vaccines: Vol 6, No 7
Product Monograph Template - Schedule D]
Poliomyelitis
DPT vaccine - Wikipedia
Clinical Review Memo - BOOSTRIX
Boostrix Product Monograph
Boostrix-Polio Product Monograph
The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - eClinicalMedicine
e150 13th International Congress on Infectious Diseases Abstracts, Poster Presentations 19.026 Co-Administration of GSK's AS04
PDF) A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps ...
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella ...
Boostrix Vaccine (Tdap Vaccine) - Bhole Children's Clinic
Local and general symptoms/signs after dTpa- IPV vaccination | Download Table
Primary Study vaccine and number Rue de l'Institut 89 1330 Rixensart, Belgium. GlaxoSmithKline (GSK) Biologicals' combined dip
Version: GDS09/IPI10
Boostrix Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Boostrix Full Prescribing Information, Dosage & Side Effects | MIMS Malaysia
Pertussis - NCIRS - National Centre for Immunisation Research and ...
